Published: May 17, 2026 · Last updated: May 17, 2026
- High-sensitivity C-reactive protein (hs-CRP) is a simple blood test that costs around $15 and measures the chronic inflammation now considered a primary driver of heart disease (Harvard Health, 2024)
- An hs-CRP result above 3 mg/L roughly doubles your cardiovascular risk compared with a result under 1 mg/L, independent of cholesterol (Harvard Health, 2024)
- Standard cholesterol panels do not include hs-CRP, so most adults have never had it measured even though most insurers cover it (Harvard Health, 2024)
Your doctor checks your blood pressure. Your cholesterol. Your blood sugar. They probably haven't ordered a high-sensitivity C-reactive protein test. And that single missing number may be the most important thing your last physical didn't tell you.
It's not a fringe test. It costs about as much as a movie ticket. Major insurers cover it. And the research connecting elevated hs-CRP to heart attacks and strokes is now twenty years deep. Yet hs-CRP is still ordered on a small fraction of routine adult check-ups. Here's what it is, what it reveals, and why asking for it is one of the highest-leverage conversations you can have with your doctor this year.
What hs-CRP Actually Measures:
C-reactive protein is a marker your liver produces in response to inflammation anywhere in your body. The high-sensitivity version (hs-CRP) is calibrated to detect the low-level chronic inflammation that drives atherosclerosis, the slow buildup of plaque in artery walls.
According to Harvard Health, 2024, the numbers break out cleanly. Below 1 mg/L is lower risk. Between 1 and 3 mg/L is average risk. Above 3 mg/L is higher risk for cardiovascular disease, heart attack, and stroke.
The Harvard reference cohort showed men with chronic inflammation roughly at the 2 mg/L threshold had three times the heart attack risk and twice the stroke risk of men with little or no detectable inflammation. That gap held even after controlling for cholesterol, blood pressure, and smoking status.
Why It Matters Independently of Cholesterol:
Cholesterol is necessary but not sufficient to explain who has heart attacks. Roughly half of first heart attacks happen in people whose LDL cholesterol falls in the "normal" range. Inflammation explains a meaningful share of that gap.
The clinical use case is the patient in the middle. If your standard risk calculator puts you at intermediate cardiovascular risk and you're not sure whether to start a statin, hs-CRP often tips the decision. A high hs-CRP in that population identifies people who benefit more from preventive treatment than the calculator alone suggests.
The American Heart Association and U.S. Preventive Services Task Force both recognize hs-CRP as a useful adjunct in this exact decision context. It is not a screening test for the entire population. It is a tie-breaker for the population most likely to benefit.
What Drives It Up:
The biggest modifiable drivers of chronic low-grade inflammation are the same ones that show up in every heart-health conversation. Excess body fat, especially visceral fat. Poor sleep. Smoking. A diet heavy in ultra-processed foods. Sedentary days. Untreated periodontal disease. Chronic psychological stress.
Per Harvard Health, 2024, the lifestyle changes that lower hs-CRP are the same ones that lower cardiovascular risk overall. Losing 5 to 10 percent of body weight, walking briskly 30 minutes most days, sleeping 7 to 8 hours, and eating a Mediterranean-pattern diet all show measurable hs-CRP reductions in published trials. Statins also lower hs-CRP independently of their cholesterol effect, which is one reason they appear to help people whose LDL is already controlled.
How to Ask for It:
The blood draw is the same blood draw you already get at your annual physical. Just add the test to the order. The lab code is "hs-CRP" or "high-sensitivity CRP." Most insurance plans cover it as a cardiovascular risk assessment, and out-of-pocket pricing at chain labs typically runs $15 to $40.
One caveat. If you have a cold, flu, recent injury, or active infection in the two weeks before the draw, the result can spike for reasons unrelated to chronic inflammation. The test is most useful when measured during a baseline-healthy stretch, then re-checked 6 to 12 months later to see the trend.
Per Harvard Health, 2022, the one-time spot reading matters less than the direction of travel. A 3.5 mg/L reading that drops to 1.2 mg/L six months later is the win. A stubbornly elevated number is a signal to dig into what's driving it.
To your health,
Ageless Coach
Age Strong. Live Long.
Trusted Sources Behind This Article
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reading this article does not create a provider-patient relationship. Always consult your physician or qualified healthcare provider before making changes to your diet, exercise, or health routine. Ageless Coach is not liable for any actions taken based on this information.
Frequently Asked Questions
Want one verified-science article like this every week?
Get Better Health, Weekly